HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Urology16 papers

Autonomic hyperreflexia of urinary bladder

Last edited: 4/15/2026

Overview

Autonomic hyperreflexia of the urinary bladder, often associated with detrusor underactivity (DU), is characterized by impaired bladder contractility leading to urinary retention and potential complications such as autonomic dysreflexia in spinal cord injury patients. 1

Diagnosis

  • Clinical history focusing on urinary retention and symptoms of bladder dysfunction.
  • Urodynamic studies to assess detrusor contractility and compliance.
  • Post-void residual (PVR) measurements to evaluate bladder emptying efficiency.
  • Imaging studies (e.g., ultrasound) to rule out anatomical obstructions.
  • Neurological evaluation, particularly in patients with spinal cord injuries. 1

    • Management

  • First-line treatments:
    • - Pharmacological options targeting detrusor function are limited; focus on symptom management. - Use of cholinergic agents like bethanechol (to stimulate detrusor contraction) may be considered, though efficacy is variable. 1
  • Adjunctive treatments:
    • - Clean intermittent catheterization (CIC) to ensure bladder emptying. - Bladder augmentation surgery in refractory cases. - Neuromodulation techniques (e.g., sacral nerve stimulation) for selected patients. 1

    Special Populations

  • Elderly: Higher incidence of DU; management focuses on conservative approaches due to limited pharmacological options. 1
  • Comorbidities: Patients with spinal cord injuries are at risk for autonomic dysreflexia; careful monitoring and management are essential. 1

    • Key Recommendations

  • Utilize urodynamic studies for definitive diagnosis of detrusor underactivity in patients with urinary retention symptoms. (Evidence: Moderate 1)
  • Implement clean intermittent catheterization as a primary supportive measure for managing urinary retention in DU. (Evidence: Moderate 1)
  • Consider cholinergic agents like bethanechol cautiously for stimulating detrusor contraction, acknowledging variable efficacy. (Evidence: Weak 1)

    • References

    1 Juszczak K, Drewa T. Pharmacotherapy in detrusor underactivity: A new challenge for urologists and pharmacologists (from lab to clinic). Pharmacological reports : PR 2016. link

    Original source

    1. [1]
      Pharmacotherapy in detrusor underactivity: A new challenge for urologists and pharmacologists (from lab to clinic). — Juszczak K, Drewa T Pharmacological reports : PR (2016)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG